Julia Chapman

Director, Portfolio Management

Julia leads Portfolio Management at Precision Biosciences. She initially came to Precision to develop our Alliance Management function where she launched and developed strategic partnerships, including our CAR T collaboration with Baxalta (now Servier), our preclinical collaboration with UPenn, and our HBV collaboration with Gilead. While at Precision, she returned to business school where she developed an interest in Strategy. She began to support development of strategic analyses, forecasting and valuation, and market research at Precision. Following graduation, she transitioned to Portfolio Management full-time. Julia came to Precision from Novartis where she supported the development of new vaccines through approval and launch. Julia also managed Pandemic Preparedness contracts with the UK and US governments and oversaw supply allocation to more than 40 global markets. During the divestiture of the Novartis Vaccines business to GSK, Julia supported the carve-out and reintegration of the Influenza business to CSL. She received her B.S.E in Biomedical Engineering from Duke University and her MBA from Duke’s Fuqua School of Business. When Julia is not at Precision, she can be found exploring the Durham food scene, strolling the Duke Gardens with her pups, or dancing salsa anywhere that salsa is danced!